Benz(B)Anthracene

Benz(B)Anthracene

SCHEMBL17849077

c1ccc2cc3cc4cc5cc6ccccc6cc5cc4cc3cc2c1.c1ccc2cc3cc4cc5ccccc5cc4cc3cc2c1.c1ccc2cc3cc4ccccc4cc3cc2c1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
HSD17B10 Q99714 4/20 0.61
TDP1 Q9NUW8 3/20 0.61
CYP3A4 P08684 2/20 0.61
CASP1 P29466 2/20 0.61
CASP7 P55210 2/20 0.61
HIF1A Q16665 2/20 0.61
ALOX15 P16050 1/20 0.61
HBB P68871 1/20 0.61
CYP2A6 P11509 7/20 0.58
ALOX12 P18054 1/20 0.58
HPGD P15428 2/20 0.53
MAPT P10636 2/20 0.53
GLA P06280 1/20 0.53
ACHE P22303 1/20 0.53
NQO2 P16083 1/20 0.50
CYP1A2 P05177 3/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25125 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
SCHEMBL25181 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
SCHEMBL54728 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
Benz(B)Anthracene SCHEMBL3474922 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
SCHEMBL3798534 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
Benz(B)Anthracene SCHEMBL7947 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
Benz(B)Anthracene SCHEMBL719854 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
Benz(B)Anthracene SCHEMBL22352910 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
SCHEMBL22634171 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
SCHEMBL31213566 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10752730-B2 Quantitative intramolecular fission in oligoacenes, materials, and methods of use thereof THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2020-08-25 US disclosed
US-20180258217-A1 QUANTITATIVE INTRAMOLECULAR FISSION IN OLIGOACENES, MATERIALS, AND METHODS OF USE THEREOF UNITED STATES DEPARTMENT OF ENERGY 2018-09-13 US disclosed
WO-2016100754-A1 QUANTITATIVE INTRAMOLECULAR FISSION IN OLIGOACENES, MATERIALS, AND METHODS OF USE THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2016-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10752730-B2 Quantitative intramolecular fission in oligoacenes, materials, and methods of use thereof SPIN1, SPIN3, ESPL1 ALDH1A1 3818/4885HSD17B10 2843/4885TDP1 1306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.